We conducted an in silico analysis integrating publicly available data from scRNAseq studies of non-tumoral brain and gliomas [26,27] with a focus on the analysis of PDE7 and GSK-3β expression in gliomas. This evidence concerns the gene GSK3B and central nervous system cancer.